• Increased att enti on has been given to women's Health-Related Quality of Life (HRQoL) impaired by various symptoms of menopause in the past years (Heinemann K, 2012 
METHODS
• A German version of the QualiPause Inventory (QPI-7D; Zoellner YK et al 2001) was used to assess the severity of the following seven menopause-specifi c symptoms on a three-stage rati ng scale ("none-moderate-severe"):
-Hot fl ushes/sweati ng -Aching joints/muscles -Anxious/frightened feelings -Breast tenderness -Irregular bleeding -Vaginal dryness -Undesirable signs of hair and skin
• A quota sample of 478 peri-or postmenopausal women, aged 45 to 60 years, was interviewed. In the fi rst part of the computer-assisted-personal-interview (CAPI), informati on about the woman's general health status, experience with the seven meno-pause symptoms, menopause status, and hormone replacement medicati on was collected.
• The second part of the interview focused on the "valuati on exercise": A total of 45 health states out of a potenti al of 2,187 states (defi ned by all possible combinati ons of the seven symptoms and the three severity-stages) were selected for valuati on. For selecti on of the health states, the Sawtooth CVA soft ware was used (Sawtooth Soft ware 2002). Diff ering from the original approach by Brazier et al. (2005) , the women evaluated only already experienced symptoms. A TTO technique was applied to esti mate the uti liti es of seven symptoms caused by menopause impairments. Health states were presented to parti cipati ng women on a mobile computer screen (see Chart 1), and they were asked to specify the willingness to give away months/years of their lives for the relief of the symptoms, using ti me-scaled graphic slide controls visible on the computer screen.
• Logisti c regression and Bayesian Regression methods were used to esti mate the uti lity values. 
RESULTS
• Respondents 478 respondents parti cipated in the study. Table 1 provides characteristi cs of this sample. Age ranged from 45 to 60 years with increasing frequency in higher age categories. Most of the parti cipants perceived their health as good or fair, only a few of them as poor (2.3%). 29.5% of the parti cipants reported irregular bleeding and 57.5% no bleeding. 13% had regular bleeding. The prevalence of hormone therapy (HRT), anti hypertensive, anti -diabeti c treatment was 21.5%, 20.7%, and 2.9%, respecti vely.
• Menopause-specifi c Symptoms Chart 2 gives an overview of the frequencies of moderate or severe symptoms. "Hot fl ushes" were menti oned most oft en, followed by "Bleedings". "Anxious/frightened feelings" were reported less frequently.
• Assigning Life Months to Relief of Menopause-specifi c Symptoms and Computi ng Uti lity Values
Willingness to "give away" months of life for relief of symptoms can range between 0 and (maximum) 132 months or 11 years. A median of 12 months was observed. 25% of the women were willing to "give away" more than 45 months, 5% more than 100 months and 1% even 132 months, or more.
• Using the methods of modelling described above (logisti c regression and Bayesian Stati sti cs) uti lity values were calculated for the seven symptoms (see Chart 3). For the relief of "Anxious/ frightened feelings -4 or more ti mes a week," the uti lity value is 0.14 which is equivalent for giving away 18.5 months. If "Anxious/frightened feelings occur only 1-3 ti mes a week," the uti lity value for relief would be 0.12 which means that the women would be willing to give away 15.8 months of life.
• This informati on can also be used to rank the importance of the seven complaints (symbolized by the length of the bars in Chart 3): The percepti on of anxious/frightening feeling got the fi rst rank of impact, followed by aching joints/muscles, breast tenderness, hot fl ushes, cosmeti c signs, vaginal dryness, and fi nally bleeding (see Chart 3).
• The uti lity values represent an additi ve model, i.e. the values of the seven complaints can be added up to provide an individual sum score. The score 1 would be equivalent to readiness to give away 132 months (11 years) of life and the score 0 means lacking willingness to give away any lifeti me for changes of menopause-specifi c HRQoL. 
